Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)
CNY 19.64
(0.46%)
CNY 19.64
(0.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 808 Million CNY | -5.47% |
| 2022 | 854.73 Million CNY | 10.54% |
| 2021 | 773.25 Million CNY | 27.25% |
| 2020 | 607.67 Million CNY | -1.43% |
| 2019 | 616.5 Million CNY | 30.55% |
| 2018 | 472.22 Million CNY | 27.12% |
| 2017 | 371.49 Million CNY | 23.61% |
| 2016 | 300.53 Million CNY | 18.32% |
| 2015 | 254 Million CNY | 10.54% |
| 2014 | 229.77 Million CNY | 23.38% |
| 2013 | 186.23 Million CNY | 33.07% |
| 2012 | 139.95 Million CNY | 44.73% |
| 2011 | 96.7 Million CNY | 80.29% |
| 2010 | 53.63 Million CNY | 63.14% |
| 2009 | 32.87 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 189.82 Million CNY | -7.19% |
| 2024 Q3 | 288.03 Million CNY | 51.74% |
| 2024 Q1 | 204.54 Million CNY | 23.83% |
| 2023 Q4 | 165.17 Million CNY | -40.16% |
| 2023 FY | 808 Million CNY | -5.47% |
| 2023 Q1 | 173.51 Million CNY | -6.29% |
| 2023 Q2 | 193.29 Million CNY | 11.4% |
| 2023 Q3 | 276.01 Million CNY | 42.79% |
| 2022 FY | 854.73 Million CNY | 10.54% |
| 2022 Q4 | 185.17 Million CNY | -37.69% |
| 2022 Q1 | 189.39 Million CNY | 5.79% |
| 2022 Q2 | 182.98 Million CNY | -3.38% |
| 2022 Q3 | 297.18 Million CNY | 62.4% |
| 2021 Q3 | 261.69 Million CNY | 49.69% |
| 2021 FY | 773.25 Million CNY | 27.25% |
| 2021 Q1 | 157.69 Million CNY | 13.43% |
| 2021 Q2 | 174.82 Million CNY | 10.86% |
| 2021 Q4 | 179.02 Million CNY | -31.59% |
| 2020 Q1 | 105.42 Million CNY | -21.3% |
| 2020 FY | 607.67 Million CNY | -1.43% |
| 2020 Q4 | 139.02 Million CNY | -37.76% |
| 2020 Q3 | 223.37 Million CNY | 59.73% |
| 2020 Q2 | 139.84 Million CNY | 32.65% |
| 2019 FY | 616.5 Million CNY | 30.55% |
| 2019 Q4 | 133.95 Million CNY | -38.53% |
| 2019 Q3 | 217.91 Million CNY | 65.76% |
| 2019 Q2 | 131.46 Million CNY | -1.28% |
| 2019 Q1 | 133.17 Million CNY | 21.04% |
| 2018 Q1 | 99.84 Million CNY | 15.19% |
| 2018 Q4 | 110.01 Million CNY | -29.85% |
| 2018 FY | 472.22 Million CNY | 27.12% |
| 2018 Q3 | 156.83 Million CNY | 48.62% |
| 2018 Q2 | 105.52 Million CNY | 5.69% |
| 2017 Q1 | 78.79 Million CNY | 9.89% |
| 2017 Q2 | 81.31 Million CNY | 3.2% |
| 2017 Q3 | 124.69 Million CNY | 53.34% |
| 2017 Q4 | 86.68 Million CNY | -30.48% |
| 2017 FY | 371.49 Million CNY | 23.61% |
| 2016 FY | 300.53 Million CNY | 18.32% |
| 2016 Q1 | 66.21 Million CNY | 7.08% |
| 2016 Q2 | 61.2 Million CNY | -7.57% |
| 2016 Q3 | 101.4 Million CNY | 65.7% |
| 2016 Q4 | 71.7 Million CNY | -29.29% |
| 2015 FY | 254 Million CNY | 10.54% |
| 2015 Q4 | 61.83 Million CNY | -23.3% |
| 2015 Q3 | 80.61 Million CNY | 46.39% |
| 2015 Q2 | 55.06 Million CNY | -2.51% |
| 2015 Q1 | 56.48 Million CNY | 0.48% |
| 2014 Q1 | 50.03 Million CNY | 10.45% |
| 2014 Q4 | 56.21 Million CNY | -22.5% |
| 2014 Q3 | 72.53 Million CNY | 42.24% |
| 2014 Q2 | 50.99 Million CNY | 1.91% |
| 2014 FY | 229.77 Million CNY | 23.38% |
| 2013 Q1 | 41.31 Million CNY | 31.86% |
| 2013 FY | 186.23 Million CNY | 33.07% |
| 2013 Q4 | 45.3 Million CNY | -20.23% |
| 2013 Q3 | 56.79 Million CNY | 32.59% |
| 2013 Q2 | 42.83 Million CNY | 3.68% |
| 2012 FY | 139.95 Million CNY | 44.73% |
| 2012 Q4 | 31.32 Million CNY | -40.93% |
| 2012 Q3 | 53.03 Million CNY | 0.0% |
| 2011 FY | 96.7 Million CNY | 80.29% |
| 2010 FY | 53.63 Million CNY | 63.14% |
| 2009 FY | 32.87 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 2.18 Billion CNY | 63.104% |
| Zhejiang Zhenyuan Share Co., Ltd. | 762.64 Million CNY | -5.947% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 458.96 Million CNY | -76.047% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 187.93 Million CNY | -329.938% |
| Yifan Pharmaceutical Co., Ltd. | 1.83 Billion CNY | 55.868% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 347.72 Million CNY | -132.371% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 10.7 Billion CNY | 92.45% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 620.91 Million CNY | -30.131% |
| Boai NKY Medical Holdings Ltd. | 894.38 Million CNY | 9.659% |